Bookmark

Add to MyYahoo RSS

Isis Pharmaceuticals News

News on Isis Pharmaceuticals (Ticker: ISIS) continually updated from thousands of sources around the net.

Friday Aug 29 | Sys-Con Media

Upcoming Conferences Schedule, Clinical Trial Data Release Schedule,...

Today, Analysts Review released its research reports regarding Celgene Corporation , Actavis plc , Regeneron Pharmaceuticals Inc. , ISIS Pharmaceuticals, Inc. and UnitedHealth Group Inc. .

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Regeneron Pharmaceuticals, Beverages, United Group, United Health Services, Hospital Administration

Thu Aug 28, 2014

AmericanBankingNews.com

ISIS Pharmaceuticals Earns "Outperform" Rating from BMO Capital Markets

's stock had its "outperform" rating reiterated by analysts at BMO Capital Markets in a research report issued to clients and investors on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Aug 27, 2014

Channel3000

Should you buy ISIS? No, not that one

You might think that a company called Isis Pharmaceuticals would be itching to change its name in order to avoid confusion with the terrorist organization Islamic State of Iraq and Syria .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Facebook, Social Software, Twitter

Sys-Con Media

Critical Alerts For Arrowhead Research, Isis Pharmaceuticals,...

To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

Comment?

Related Topix: Biotech, Medicine, Arrowhead Research, Healthcare Industry, Banking, JP Morgan Chase , Viacom

Tue Aug 26, 2014

Benzinga

CNBC's Stock Pops & Drops From August 26

CNBC Fast Money's Guy Adami said on the show that there is a lot of news in the biotech space and ISIS Pharmaceuticals is right in the middle of it.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Apparel, DSW

Silicon Alley Insider

A Company Called ISIS Had A Massive Day On The Stock Market

ISIS, or the Islamic State of Iraq and Syria, has gotten lots of attention for the terror it has brought to the Middle East.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Science / Technology, Financial Markets

Forbes.com

Tuesday's ETF Movers: XBI, XLU

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.

Comment?

Related Topix: Biotech, Arrowhead Research, Medicine, Healthcare Industry, Financial Markets

Thu Aug 21, 2014

New York Magazine

Other Things Called ISIS Not Necessarily Changing Their Names

To many, the name ISIS has become synonymous with the Islamic State in Iraq and Syria, the terrorist group responsible for the brutal killing of journalist James Foley earlier this week.

Comment?

Related Topix: Terrorism, Fordham University, Biotech, Medicine, Healthcare Industry, Sports

Sat Aug 16, 2014

AmericanBankingNews.com

Stanley T. Crooke Sells 15,500 Shares of ISIS Pharmaceuticals Stock

ISIS Pharmaceuticals CEO Stanley T. Crooke unloaded 15,500 shares of the company's stock in a transaction dated Wednesday, August 13th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Aug 15, 2014

Sys-Con Media

Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in ...

The open-label extension study of ISIS-SMNRx is offered to those children with SMA who have completed dosing in Isis' previous studies.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Biogen Idec

Tue Aug 12, 2014

AmericanBankingNews.com

ISIS Pharmaceuticals Receives Average Rating of "Hold" from Brokerages

Shares of ISIS Pharmaceuticals have been given a consensus recommendation of "Hold" by the thirteen ratings firms that are presently covering the company, AnalystRatings.Net reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Aug 11, 2014

Sys-Con Media

Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2014

Summary GlobalData's clinical trial report, "Spinal Muscular Atrophy Global Clinical Trials Review, H2, 2014" provides data on the Spinal Muscular Atrophy clinical trial scenario.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Scientific Instruments, Hillenbrand Industries, Medical Equipment

Sat Aug 09, 2014

Seeking Alpha

Alnylam Pharmaceuticals Has Plenty On Its Plate

Alnylam will exceed its 5x15 target and should have at least a half-dozen human clinical trial programs underway in 2015.

Comment?

Related Topix: Healthcare Industry, Biotech, Sirna Therapeutics, Alnylam Pharmaceuticals

Fri Aug 08, 2014

AmericanBankingNews.com

ISIS Pharmaceuticals Given Average Rating of "Hold" by Brokerages

Shares of ISIS Pharmaceuticals have been given a consensus recommendation of "Hold" by the thirteen ratings firms that are currently covering the company, Analyst Ratings Network.com reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Sys-Con Media

Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals,...

To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

Comment?

Related Topix: Stratasys, Computers, Computer-Aided Design, Manufacturing and Engineering, Software, Biotech, Medicine, Healthcare Industry, Amgen, Financial Services, Discover Financial Services

Mon Aug 04, 2014

BioSpace

Isis Pharmaceuticals, Inc. Reports Financial Results And Highlights For Second Quarter 2014

Isis' pro forma operating income in the second quarter of 2014 was primarily driven by more than of milestone payments from partners the Company earned during the second quarter.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Biogen Idec

•••
•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••